Zealand Pharma A/S (LON:0NZU)
323.31
-19.94 (-5.81%)
At close: Aug 1, 2025
Exscientia Market Cap
Zealand Pharma has a market cap or net worth of 2.71 billion as of August 1, 2025. Its market cap has decreased by -63.50% in one year.
Market Cap
2.71B
Enterprise Value
1.76B
Revenue
6.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
$323.31
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 159.84M to 2.71B, an increase of 1,597.41%. That is a compound annual growth rate of 21.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 2.71B | -51.74% |
Dec 30, 2024 | 5.62B | 121.65% |
Dec 29, 2023 | 2.54B | 105.19% |
Dec 30, 2022 | 1.24B | 74.70% |
Dec 30, 2021 | 707.55M | -33.54% |
Dec 30, 2020 | 1.06B | 9.92% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 178.30B |
HSBC Holdings | 160.62B |
Shell | 157.43B |
Unilever | 111.06B |
British American Tobacco p.l.c. | 87.18B |
Rolls-Royce Holdings | 82.38B |
Rio Tinto Group | 78.40B |
RELX PLC | 71.47B |